ECM
ExodusPoint Capital Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $81.2M | Buy |
755,867
+194,602
| +35% | +$20.9M | 0.71% | 8 |
|
|
2025
Q1 | $56.6M | Buy |
561,265
+257,901
| +85% | +$26M | 0.56% | 14 |
|
|
2024
Q4 | $27.1M | Sell |
303,364
-700,160
| -70% | -$62.5M | 0.19% | 69 |
|
|
2024
Q3 | $84.1M | Buy |
1,003,524
+323,831
| +48% | +$27.1M | 0.51% | 11 |
|
|
2024
Q2 | $52.3M | Buy |
679,693
+451,884
| +198% | +$34.8M | 0.36% | 21 |
|
|
2024
Q1 | $15.6M | Buy |
+227,809
| New | +$15.6M | 0.12% | 107 |
|
|
2023
Q3 | – | Sell |
-362,484
| Closed | -$19.6M | – | 1667 |
|
|
2023
Q2 | $19.6M | Buy |
362,484
+201,709
| +125% | +$10.9M | 0.16% | 92 |
|
|
2023
Q1 | $8.04M | Buy |
+160,775
| New | +$8.04M | 0.07% | 278 |
|
|
2022
Q3 | – | Sell |
-92,295
| Closed | -$3.44M | – | 1857 |
|
|
2022
Q2 | $3.44M | Sell |
92,295
-88,212
| -49% | -$3.29M | 0.04% | 518 |
|
|
2022
Q1 | $8M | Buy |
180,507
+89,134
| +98% | +$3.95M | 0.1% | 222 |
|
|
2021
Q4 | $3.88M | Sell |
91,373
-26,753
| -23% | -$1.14M | 0.04% | 495 |
|
|
2021
Q3 | $5.13M | Buy |
118,126
+56,649
| +92% | +$2.46M | 0.07% | 360 |
|
|
2021
Q2 | $2.63M | Sell |
61,477
-72,020
| -54% | -$3.08M | 0.03% | 510 |
|
|
2021
Q1 | $5.16M | Sell |
133,497
-110,976
| -45% | -$4.29M | 0.08% | 235 |
|
|
2020
Q4 | $8.79M | Buy |
244,473
+227,754
| +1,362% | +$8.19M | 0.09% | 124 |
|
|
2020
Q3 | $639K | Sell |
16,719
-121,691
| -88% | -$4.65M | 0.01% | 832 |
|
|
2020
Q2 | $4.86M | Buy |
138,410
+19,304
| +16% | +$678K | 0.13% | 155 |
|
|
2020
Q1 | $3.89M | Buy |
119,106
+113,148
| +1,899% | +$3.69M | 0.21% | 62 |
|
|
2019
Q4 | $269K | Sell |
5,958
-15,434
| -72% | -$697K | 0.01% | 1151 |
|
|
2019
Q3 | $870K | Buy |
+21,392
| New | +$870K | 0.03% | 403 |
|